Search
Now showing items 1-2 of 2
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
(Vascular medicine (London, England), 2018-12)
Patients with peripheral artery disease (PAD) are at heightened risk of cardiovascular
morbidity and mortality. We sought to evaluate the risk of concomitant coronary artery
disease (CAD) in patients with symptomatic PAD ...
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.
(Journal of the American Heart Association, 2018-10)
Background In the EXSCEL (Exenatide Study of Cardiovascular Event Lowering), exenatide
once-weekly resulted in a nonsignificant reduction in major adverse cardiovascular
events ( MACEs ) and a nominal 14% reduction in all-cause ...